IL4 and Alzheimer disease: To date, the significant reported findings are that type 2 cytokines IL-4-, IL-13-, and IL-31-induced IL-24 pathway causes downregulation of FLG and LOR, which is a mechanism contributing to barrier disruption in AD [15,30,31].